Hepatitis	O
B	O
virus	O
integration	O
event	O
in	O
human	O
chromosome	B-Cellular_component
17p	I-Cellular_component
near	O
the	O
p53	O
gene	O
identifies	O
the	O
region	O
of	O
the	O
chromosome	B-Cellular_component
commonly	O
deleted	O
in	O
virus	B-Cancer
-	I-Cancer
positive	I-Cancer
hepatocellular	I-Cancer
carcinomas	I-Cancer
.	O

The	O
development	O
of	O
hepatocellular	B-Cancer
carcinoma	I-Cancer
(	O
HCC	B-Cancer
)	O
presumably	O
occurs	O
in	O
multiple	O
steps	O
and	O
is	O
influenced	O
by	O
numerous	O
factors	O
.	O

Hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
is	O
strongly	O
associated	O
with	O
the	O
development	O
of	O
HCC	B-Cancer
in	O
people	O
chronically	O
infected	O
with	O
the	O
virus	O
,	O
but	O
the	O
mechanism	O
of	O
viral	O
involvement	O
remains	O
unclear	O
.	O

One	O
possibility	O
is	O
that	O
the	O
gross	O
chromosomal	B-Cellular_component
alterations	O
frequently	O
observed	O
in	O
HCC	B-Cancer
DNA	O
at	O
the	O
site	O
of	O
HBV	O
integration	O
may	O
alter	O
the	O
expression	O
of	O
important	O
nearby	O
cellular	B-Cell
genes	O
.	O

We	O
previously	O
reported	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
HBV	O
insert	O
from	O
a	O
Chinese	O
HCC	B-Cancer
.	O

The	O
viral	O
insert	O
mapped	O
to	O
chromosome	B-Cellular_component
17p11	I-Cellular_component
.	I-Cellular_component
2	I-Cellular_component
-	I-Cellular_component
12	I-Cellular_component
,	O
and	O
cellular	B-Cell
sequences	O
were	O
duplicated	O
at	O
the	O
site	O
of	O
viral	O
integration	O
.	O

In	O
the	O
present	O
study	O
a	O
DNA	O
probe	O
derived	O
from	O
cellular	B-Cell
DNA	O
sequences	O
adjacent	O
to	O
the	O
previously	O
characterized	O
HBV	O
insert	O
was	O
used	O
to	O
analyze	O
a	O
set	O
of	O
19	O
matched	O
normal	O
liver	B-Organ
and	O
HBV	O
-	O
positive	O
hepatoma	B-Tissue
samples	I-Tissue
obtained	O
from	O
the	O
same	O
region	O
of	O
China	O
,	O
near	O
Shanghai	O
.	O

Tumor	B-Cancer
-	O
specific	O
DNA	O
changes	O
were	O
detected	O
in	O
two	O
additional	O
HCCs	B-Cancer
,	O
suggesting	O
that	O
the	O
small	O
region	O
of	O
chromosome	B-Cellular_component
17p	I-Cellular_component
defined	O
by	O
the	O
flanking	O
cell	B-Cell
DNA	O
probe	O
is	O
commonly	O
altered	O
in	O
hepatomas	B-Cancer
.	O

Restriction	O
fragment	O
length	O
polymorphism	O
studies	O
demonstrated	O
that	O
the	O
loss	O
of	O
one	O
copy	O
of	O
portions	O
of	O
chromosome	B-Cellular_component
17	I-Cellular_component
occurred	O
in	O
10	O
(	O
53	O
%	O
)	O
of	O
the	O
19	O
patients	O
.	O

The	O
loss	O
of	O
one	O
allele	O
of	O
the	O
p53	O
gene	O
(	O
located	O
on	O
chromosome	B-Cellular_component
17p13	I-Cellular_component
)	O
occurred	O
in	O
at	O
least	O
6	O
(	O
60	O
%	O
)	O
of	O
the	O
10	O
patients	O
who	O
were	O
heterozygous	O
at	O
the	O
p53	O
locus	O
.	O

As	O
the	O
p53	O
gene	O
is	O
known	O
to	O
possess	O
tumor	B-Cancer
suppressor	O
activity	O
,	O
the	O
functional	O
loss	O
of	O
this	O
gene	O
may	O
be	O
a	O
significant	O
step	O
in	O
the	O
development	O
of	O
a	O
subset	O
of	O
HCCs	B-Cancer
.	O

High	O
levels	O
of	O
allele	O
loss	O
also	O
were	O
detected	O
for	O
chromosomes	B-Cellular_component
8q	I-Cellular_component
(	O
4	O
of	O
9	O
;	O
44	O
%	O
)	O
and	O
16p	B-Cellular_component
(	O
5	O
of	O
6	O
;	O
83	O
%	O
)	O
and	O
may	O
indicate	O
the	O
presence	O
of	O
additional	O
cellular	B-Cell
genes	O
whose	O
functional	O
loss	O
is	O
important	O
in	O
the	O
development	O
of	O
HCCs	B-Cancer
.	O

